Yiheng Capital »

Crispr Therapeutics shares owned by Yiheng Capital

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Yiheng Capital from 13F filings

Historical chart of Yiheng Capital investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Yiheng Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Yiheng Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 274k 62.60

More positions owned by Yiheng Capital

Jd.com Spon Adr Cl A Call Option (JD)
Bilibili Spons Ads Rep Z Call Option (BILI)
Roblox Corp Cl A (RBLX)
New Oriental Ed & Technology Spon Adr (EDU)
H World Group Sponsored Ads (HTHT)
Noah Hldgs Spon Ads (NOAH)
TransDigm Group Incorporated (TDG)
Akero Therapeutics (AKRO)
Miragen Therapeutics (VRDN)
Denali Therapeutics (DNLI)
Tal Education Group Sponsored Ads (TAL)
Beam Therapeutics (BEAM)
Crispr Therapeutics Namen Akt Put Option (CRSP)
Inventiva Sa Ads (IVA)
Acm Resh Com Cl A (ACMR)

View all positions for Yiheng Capital

Top funds holding Crispr Therapeutics

ARK Investment Management
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Citadel Advisors
Vanguard Group
NEA Management Company
Caption Management
Bellevue Group
Credit Suisse
T. Rowe Price Associates
Bank of America Corporation
Dimensional Fund Advisors
Voloridge Investment Management
Ikarian Capital
Charles Schwab Investment Management

View all funds holding Crispr Therapeutics